History’s deadliest infectious disease has a new adversary. Although many think of tuberculosis as a disease of the past, it still kills 1.2 million people annually. Last month, scientists at Texas A&M AgriLife Research published a study in Nature, revealing that they had developed a new compound that could be a tuberculosis treatment breakthrough. The…| Drug Discovery and Development
Eschbach's visual factory approach helps pharmaceutical plants overcome data chaos by using SQDCP boards and AI to provide clear, actionable insights, enabling teams to make faster, more informed decisions and accelerate batch release.| Drug Discovery and Development
By Vinita Navadgi | October 3, 2025| Drug Discovery and Development
Eli Lilly’s TuneLab shares AI drug discovery models with biotech partners, aiming to speed pharmaceutical R&D through collaboration and machine learning.| Drug Discovery and Development
Drug Discovery and Development covers strategies and technologies related to pharmaceutical research and development and drug formulation.| Drug Discovery and Development
By Brian Buntz | June 23, 2025| Drug Discovery and Development
By Julia Rock-Torcivia | June 9, 2025| Drug Discovery and Development
By Julia Rock-Torcivia | June 9, 2025| Drug Discovery and Development
By Julia Rock-Torcivia | June 9, 2025| Drug Discovery and Development
By Brian Buntz | June 25, 2025| Drug Discovery and Development
By Dr. Qigan Cheng | August 18, 2025| Drug Discovery and Development
How biomarker discovery automation—spanning assay analytics, metadata capture, and data lineage—enables reproducible results across omics, imaging, and clinical data.| Drug Discovery and Development
Effective long-term follow-up in vaccine clinical trials is crucial. Explore key considerations for study design, patient tokenization, and regulatory compliance.| Drug Discovery and Development
IQVIA experts explain how implementation science accelerates adoption of medical advances, improving evidence-based care and patient outcomes.| Drug Discovery and Development
By Ryan N. Phelan | April 28, 2025| Drug Discovery and Development
Tarsus aims to expand the lotilaner pipeline with potential treatments for ocular rosacea, Lyme disease and malaria.| Drug Discovery and Development
Bispecific antibodies are a rapidly advancing class of therapeutics, offering a new level of precision in treating diseases like cancer.| Drug Discovery and Development
Cedars-Sinai researchers boost ACE enzyme in brain immune cells, dramatically reducing Alzheimer's plaques and reversing cognitive decline in mice.| Drug Discovery and Development
Eli Lilly and Co. has agreed to buy Verve Therapeutics Inc. for up to $1.3 billion, in a move that bolsters Lilly's push into gene editing for cardiovascular conditions and signals renewed confidence in the sector.| Drug Discovery and Development
Discover GREmLN, a novel foundation model from Columbia and Chan Zuckerberg Biohub, that achieves superior cell-type classification with a compact design.| Drug Discovery and Development
Drug Discovery and Development covers strategies and technologies related to pharmaceutical research and development and drug formulation.| Drug Discovery and Development
By Brian Buntz | September 8, 2025| Drug Discovery and Development
By Vinita Navadgi | October 3, 2025| Drug Discovery and Development
Genmab, a Danish company focused on developing antibody therapies for patients with cancer, opened a new site in Plainsboro, NJ.| Drug Discovery and Development
Nektar Therapeutics stock skyrocketed 287% after rezpegaldesleukin hit all endpoints in atopic dermatitis trials, but ongoing litigation with Lilly could complicate matters.| Drug Discovery and Development
Dupixent (dupilumab) has been approved by the FDA for the treatment of adult patients with bullous pemphigoid.| Drug Discovery and Development
The phase 4 EVEREST study showed that Dupixent demonstrated superiority over Xolair in adults with chronic rhinosinusitis.| Drug Discovery and Development
By Will Torres, Maryam Youssef and Kasia Koczula | July 9, 2025| Drug Discovery and Development
By Julia Rock-Torcivia | September 22, 2025| Drug Discovery and Development
Drug Discovery and Development covers strategies and technologies related to pharmaceutical research and development and drug formulation.| Drug Discovery and Development
Cambridge-based biotechnology company Parallel Bio has closed a $21 million Series A funding round led by AIX Ventures.| Drug Discovery and Development
Drug Discovery and Development covers strategies and technologies related to pharmaceutical research and development and drug formulation.| Drug Discovery and Development
Drug Discovery and Development covers strategies and technologies related to pharmaceutical research and development and drug formulation.| Drug Discovery and Development
Sanofi and Regeneron have announced that the monoclonal antibody outperformed Xolair (omalizumab) on all primary and secondary efficacy endpoints in a phase 4 study focused on patients with chronic rhinosinusitis.| Drug Discovery and Development
The FDA has approved zoliflodacin for the treatment of uncomplicated gonorrhea in adults and pediatric patients 12 years and older.| Drug Discovery and Development
The FDA has approved ENFLONSIA for the prevention of RSV lower respiratory tract disease in infants and newborns.| Drug Discovery and Development
Just over three-quarters of patients receiving Sanofi and Regeneron’s Dupixent achieved at least a 75% improvement in disease severity.| Drug Discovery and Development
Labcorp rolls out new NGS panels, HRD testing, and a Leica-Proscia digital pathology platform to accelerate biomarker screening.| Drug Discovery and Development
From accelerating drug discovery and optimizing clinical trials to automating regulatory documentation and improving patient engagement, AI offers opportunities to improve efficiency, reduce costs, and bring therapies to market faster.| Drug Discovery and Development
The once pioneering DNA test company 23andMe is now a penny stock that has filed for bankruptcy. Its CEO Anne Wojcicki is also stepping down.| Drug Discovery and Development
They are highly effective at suppressing inflammation and the reducing the activity of the body’s immune system, providing rapid relief from associated symptoms.| Drug Discovery and Development
By Brian Buntz | February 19, 2025| Drug Discovery and Development
By Brian Buntz | April 30, 2025| Drug Discovery and Development
Drug Discovery and Development covers strategies and technologies related to pharmaceutical research and development and drug formulation.| Drug Discovery and Development
AnaptysBio’s investigational drug rosnilimab has delivered promising Phase 2b trial results for moderate-to-severe rheumatoid arthritis.| Drug Discovery and Development
Capturing complete, consistent, and contextualized data is vital in AI/ML, especially within the biopharma industry.| Drug Discovery and Development
$1B women's health push and RNAi advances mark JPM 2025, with solid tumor therapies gaining momentum| Drug Discovery and Development
Novo Nordisk continues to face supply shortages for its Wegovy (semaglutide) pens, which are FDA approved for weight management.| Drug Discovery and Development
